Sort
15,842 grants matching “pancreatic cancer”
A Patient-Centric Approach to Advance Functional Precision Oncology
$1,007,878Christopher J Kemp · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$1,007,323John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability
$1,006,666Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R35 · FY2019 · CA
Mitigation of Radiation Induced Gastrointestinal Syndrome.
$1,005,819Andrew John Norris · Bcn Biosciences, Llc · R44 · FY2024 · AI
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$1,004,910William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Computational Tools For Bioinformatics And Genome Analysis
$1,004,300John I Powell · Center For Information Technology · ZIA · FY2014 · CT
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$1,004,043Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
United for Health Equity - Living PDX Program (U4HELPP)
$1,003,591Jose G. Trevino · Virginia Commonwealth University · U54 · FY2025 · CA
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
$1,002,483Valerie Humblet · Collagen Medical, Llc · R44 · FY2017 · CA
Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response
$1,002,287Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2024 · CA
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,001,634Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images
$1,000,481Debiao Li · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Development of GPER Agonists as Cancer Therapeutics
$1,000,000Tina Garyantes · Linnaeus Therapeutics, Llc · R44 · FY2019 · CA
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$1,000,000Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2019 · CA
Development of GPER Agonists as Cancer Therapeutics
$1,000,000Tina Garyantes · Linnaeus Therapeutics, Llc · R44 · FY2020 · CA
SIRPant Technology for anti-Cancer Immunity
$1,000,000Nathanael McCurley · Sirpant Immunotherapeutics, Inc. · R42 · FY2023 · CA
Non-invasive staging of Metastasis by Precision MRI
$1,000,000Yiting Xu · Inlighta Biosciences, Llc · R44 · FY2023 · CA
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
$1,000,000Ying Yuan · University Of Tx Md Anderson Can Ctr · U01 · FY2018 · DK
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
$1,000,000Ziding Feng · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · DK
Bridging Interventional Development Gaps (BrIDGs)
$1,000,000Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2019 · CA
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
$1,000,000Ying Yuan · University Of Tx Md Anderson Can Ctr · U01 · FY2018 · DK
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$1,000,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2018 · CA
SIRPant Technology for anti-Cancer Immunity
$999,999Nathanael McCurley · Bobcatbio, Inc. · R42 · FY2024 · CA
Development of a protein drug for pancreatic cancer treatment
$999,780Zhi-Ren Liu · Proda Biotech, Llc · R42 · FY2018 · CA